Occidental Petroleum's Options Frenzy: What You Need to Know - Occidental Petroleum ( NYSE:OXY )
Investors with a lot of money to spend have taken a bullish stance on Occidental Petroleum OXY. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Corcept Therapeutics's Options Frenzy: What You Need to Know - Corcept Therapeutics ( NASDAQ:CORT )
Financial giants have made a conspicuous bullish move on Corcept Therapeutics. Our analysis of options history for Corcept Therapeutics CORT revealed 38 unusual trades. Delving into the details, we found 42% of traders were bullish, while 34% showed bearish tendencies.
3 Pipeline Stocks to Buy With $1,000 and Hold Forever
If you're looking for stocks with consistent, predictable business models that pay attractive distributions and have robust yields, the pipeline sector is one of the best places to look. The sector as a whole is inexpensive versus historical levels, while the current environment is one of the ...
NEM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Newmont Corporation Investors to Secure Counsel Before Important April 1 Deadline in Securities Class Action - NEM - Newmont ( NYSE:NEM )
NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Newmont Corporation NEM between February 22, 2024 and October 23, 2024, inclusive ( the "Class Period" ) , of the important April 1, 2025 lead plaintiff ...
GUESS JEANS and Nicolai Marciano announce an exciting new creative partnership with world renowned Japanese multi-hyphenated artist VERDY. - Guess ( NYSE:GES )
LOS ANGELES, March 31, 2025 /PRNewswire/ -- GUESS JEANS and Chief New Business Development Officer, Nicolai Marciano announce an exciting new creative partnership with Japanese multi-hyphenate Artist VERDY. This partnership marks the beginning of something special, blending VERDY's contemporary ...
Lost Money on Integral Ad Science Holding Corp. ( IAS ) ? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm - Integral Ad Science Holdi ( NASDAQ:IAS )
NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Integral Ad Science Holding Corp. IAS. Shareholders who purchased shares of IAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
Can Block Stock Double by 2030? History Says Its Secret Weapon Will Reward Investors.
In the five-year period leading up to its all-time high in August 2021, shares of Block ( NYSE: XYZ ) were up an astonishing 2,430%. They were certainly a favorite among the investment community.However, it's been a much more pessimistic story since then.
FLNC LAWSUIT ALERT: The Gross Law Firm Notifies Fluence Energy, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Fluence Energy ( NASDAQ:FLNC )
NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Fluence Energy, Inc. FLNC. Shareholders who purchased shares of FLNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Elastic N.V. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ESTC - Elastic ( NYSE:ESTC )
NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Elastic N.V. ESTC. Shareholders who purchased shares of ESTC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
New Data Strengthens Teva's Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 ( olanzapine ) as a Once-Monthly Subcutaneous Long-Acting Injectable
PARSIPPANY, N.J. and TEL AVIV, Israel, March 31, 2025 ( GLOBE NEWSWIRE ) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , today announced the presentation of a patient and healthcare professional ( HCP ) attitudes and experiences survey ...
